[{"address1": "201 Haskins Way", "address2": "Suite 230", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650-407-2376", "website": "https://www.cero.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Daniel Mark Corey M.D.", "age": 44, "title": "Founder, CTO & Director", "yearBorn": 1979, "fiscalYear": 2022, "totalPay": 372685, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian G. Atwood", "age": 70, "title": "President, CEO & Chairman", "yearBorn": 1953, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles Ross Carter", "age": 55, "title": "CFO, Treasurer & Corporate Secretary", "yearBorn": 1968, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert  Sikorski M.D., Ph.D.", "age": 60, "title": "Consultant", "yearBorn": 1963, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.43, "open": 1.44, "dayLow": 1.4, "dayHigh": 1.49, "regularMarketPreviousClose": 1.43, "regularMarketOpen": 1.44, "regularMarketDayLow": 1.4, "regularMarketDayHigh": 1.49, "beta": -0.362, "volume": 71211, "regularMarketVolume": 71211, "averageVolume": 1099572, "averageVolume10days": 109810, "averageDailyVolume10Day": 109810, "marketCap": 20760276, "fiftyTwoWeekLow": 1.33, "fiftyTwoWeekHigh": 12.8, "fiftyDayAverage": 2.49628, "twoHundredDayAverage": 8.674505, "currency": "USD", "enterpriseValue": 22218354, "floatShares": 7048760, "sharesOutstanding": 14723600, "sharesShort": 26840, "sharesShortPriorMonth": 119558, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.0018000001, "heldPercentInsiders": 0.35999, "heldPercentInstitutions": 0.14897999, "shortRatio": 0.02, "shortPercentOfFloat": 0.0023999999, "impliedSharesOutstanding": 14723600, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -2536233, "52WeekChange": -0.8723982, "SandP52WeekChange": 0.21080327, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "CERO", "underlyingSymbol": "CERO", "shortName": "CERo Therapeutics Holdings, Inc", "longName": "CERo Therapeutics Holdings, Inc.", "firstTradeDateEpochUtc": 1638282600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c96e7212-658f-3054-8625-d2aafea7c5eb", "messageBoardId": "finmb_1673740339", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.41, "recommendationKey": "none", "totalCash": 96873, "totalCashPerShare": 0.007, "totalDebt": 1555000, "quickRatio": 0.019, "currentRatio": 1.655, "returnOnAssets": -0.07199, "freeCashflow": 5114389, "operatingCashflow": -1523604, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-26"}]